Vardenafil can improve continence recovery after bilateral nerve sparing prostatectomy: Results of a randomized, double blind, placebo-controlled pilot study

Journal of Sexual Medicine

Volumn 7, Issue 1 PART 1, 2010, Pages 234-243

  Gacci, Mauro ^a   Ierardi, Alessandro ^a   Rose, Augusto Delle ^a   Tazzioli, Stefano ^a   Scapaticci, Emanuele ^b   Filippi, Sandra ^a   Maggi, Mario ^a   Nicita, Giulio ^a   Carini, Marco ^a   Montorsi, Francesco ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Bilateral nerve sparing; PDE5 I; Prostate cancer; Radical prostatectomy; Urinary continence rehabilitation; Vardenafil

Indexed keywords

PLACEBO; VARDENAFIL;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG USE; HUMAN; MALE; MICTURITION; MULTICENTER STUDY; NERVE SURGERY; OUTCOME ASSESSMENT; PILOT STUDY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL;

EID: 74049144034     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01471.x     Document Type: Article

References (27)

1. Krupski TL, Saigal CS, Litwin MS. Variation in continence and potency by definition. J Urol 2003, 170:1291-4.
2. Litwin MS, Melmed GY, Nakazon T. Life after prostatectomy: A longitudinal study. J Urol 2001, 166:587-92.
3. Briganti A, Salonia A, Gallina A, Chun FK, Karakiewicz PI, Graefen M, Huland H, Rigatti P, Montorsi F. Management of erectile dysfunction after radical prostatectomy in 2007. World J Urol 2007, 25:143-8.
4. McVary KT, Roehrborn CG, Kaminetsky JC, Auerbach SM, Wachs B, Young JM, Esler A, Sides GD, Denes BS. The efficacy and safety of tadalafil administered once a day for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH). J Urol 2006, 175:527.
5. McVary KT, Monnig W, Camps JL, Young JM, Tseng LJ, van den Ende G. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tracts symptoms associated with benign prostatic hyperplasia: A randomized, double-blind trial. J Urol 2007, 177:1071-7.
6. Stief CG, Porst H, Neuser D, Beneke M, Ulbrich E. A randomized, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2008, 53:1236-44.
7. Oger S, Behr-Roussel D, Gorny D, Lebret T, Denoux Y, Alexandre L, Giuliano F. Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human detrusor and prostatic tissues in vitro. Eur Urol 2009, May, May 3. [Epub ahead of print]
8. Oger S, Behr-Roussel D, Gorny D, Lecoz O, Lebret T, Denoux Y, Faix A, Leriche A, Wayman C, Alexandre L, Giuliano F. Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue. J Sex Med 2009, 6:836-47.
9. Filippi S, Morelli A, Sandner P, Fibbi B, Mancina R, Marini M, Gacci M, Vignozzi L, Vannelli GB, Carini M, Forti G, Maggi M. Characterization and functional role of an androgen-dependent PDE5 activity in the bladder. Endocrinology 2007, 148:1019-29.
10. Morelli A, Filippi S, Sandner P, Fibbi B, Chavalmane AK, Silvestrini E, Sarchielli E, Vignozzi L, Gacci M, Carini M, Vannelli GB, Maggi M. Vardenafil modulates bladder contractility through cgmp-mediated inhibition of rhoa/rho kinase signaling pathway in spontaneously hypertensive rats. J Sex Med 2009, 6:1594-608.
11. Gacci M, Livi L, Paiar F, Detti B, Litwin MS, Bartoletti R, Giubilei G, Cai T, Mariani M, Carini M. Quality of life after radical treatment of prostate cancer: Validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index. Urology 2005, 66:338-43.
12. De Lean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978, 235:E97-102.
13. Giuliano F. Phosphodiesterase type 5 inhibitors improve male lower urinary tract symptoms. Eur Urol 2008, 53:1121-4.
14. John H, Suter S, Hauri D. Effect of radical prostatectomy on urethral blood flow. Urology 2002, 59:566-9.
15. Andersson KE. Bladder activation: Afferent mechanisms. Urology 2002, 59(1):43-50. Suppl, Review
16. Tinel H, Stelte-Ludwig B, Hutter J, Sandner P. Preclinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms. BJU Int 2006, 98:1259-63.
17. Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG. Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: Present and future. Eur Urol 2006, 50:1194-207.
18. Giuliano F, Amar E, Chevallier D, Montaigne O, Joubert JM, Chartier-Kastler E. How urologists manage erectile dysfunction after radical prostatectomy: A national survey (REPAIR) by the French Urological Association. J Sex Med 2008, 5:448-57.
19. Walsh PC, Marschke P, Ricker D. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000, 55:58-61.
20. Sacco E, Prayer-Galetti T, Pinto F, Fracalanza S, Betto G, Pagano F, Artibani W. Urinary continence after radical prostatectomy: Incidence by definition, risk factors and temporal trend in a large series with long term follow up. BJU Int 2006, 97:1234-41.
21. Walsh PC. Radical prostatectomy for localized prostate cancer provides durable cancers control with excellent quality of life: A structured database. J Urol 2000, 163:1802-7.
22. Gacci M, Del Popolo G, Macchiarella A, Celso M, Vittori G, Lapini A, Serni S, Sandner P, Maggi M, Carini M. Vardenafil improves urodynamic parameters in men with spinal cord injury: Results from a single dose, pilot study. J Urol 2007, 178:2040-3.
23. Moinzadeh A, Shunaigat AN, Libertino JA. Urinary incontinence after radical retropubic prostatectomy: The outcomes of a surgical technique. BJU Int 2003, 92:355-9.
24. Padma-Nathan H, McCullough AR, Levine LA. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 2008, 20:479-86.
25. Pimentel H, Wald M, Niederberger C. Daily use of phosphodiesterase 5 inhibitors for erectile dysfunction and lower urinary tract symptoms. Int J Impot Res 2008, 20:145-9.
26. Takenaka A, Soga H, Miyake TKH, Tanaka K, Fujisawa M. Early recovery of urinary continence after laparoscopic versus retropubic radical prostatectomy: Evaluation of preoperative erectile function and nerve-sparing procedure as predictors. Int Urol Nephrol 2009, 41:587-93.
27. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, Stief C. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008, 54:924-31.